ResearcherThe Honourable Society of Lincoln's InnActive in the last 2 years
Axel Behrens
Matched on ORCID iD 0000-0002-1557-1143; OpenAlex author ID A5047482056. Sources: OpenAlex.
Their work
- Papers
- 10 (first author 0, last author 7)
- Trials
- 0
- Grants
- 0
- Labs led
- 2
- Collaborators
- 17
2016: 1 paper · 2017: none · 2018: none · 2019: 2 papers · 2020: none · 2021: none · 2022: 3 papers · 2023: 1 paper · 2024: none · 2025: 2 papers · 2026: 1 paper
Papers 10
- A Jagged1-regulated hybrid-EMT state identifies pancreatic cancer stem cells. Last author DOI 10.1016/j.celrep.2025.116909↗
- Emerging insights into lineage plasticity in pancreatic cancer initiation, progression, and therapy resistance. Co-author DOI 10.1016/j.devcel.2025.07.002↗
- SPP1 is required for maintaining mesenchymal cell fate in pancreatic cancer. Last author DOI 10.1038/s41586-025-09574-y↗
- A small Rho GTPase RAB25 with a potential role in chemotherapy resistance in pancreatic cancer. Co-author DOI 10.3233/cbm-220214↗
- The roles of intratumour heterogeneity in the biology and treatment of pancreatic ductal adenocarcinoma. Last author DOI 10.1038/s41388-022-02448-x↗
- USP25 promotes pathological HIF-1-driven metabolic reprogramming and is a potential therapeutic target in pancreatic cancer. Last author DOI 10.1038/s41467-022-29684-9↗
- GREM1 is required to maintain cellular heterogeneity in pancreatic cancer. Last author DOI 10.1038/s41586-022-04888-7↗
- CD9 identifies pancreatic cancer stem cells and modulates glutamine metabolism to fuel tumour growth. Last author DOI 10.1038/s41556-019-0407-1↗
- MDH1 and MPP7 Regulate Autophagy in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/0008-5472.can-18-2553↗
- YAP1 and TAZ Control Pancreatic Cancer Initiation in Mice by Direct Up-regulation of JAK-STAT3 Signaling. Last author DOI 10.1053/j.gastro.2016.05.006↗
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Linxiang Lan · 4 shared papers, 2022–2026 · strength 0.96
- Paper Emerging insights into lineage plasticity in pancreatic cancer initiation, progression, and therapy resistance. DOI 10.1016/j.devcel.2025.07.002↗
- Paper A Jagged1-regulated hybrid-EMT state identifies pancreatic cancer stem cells. DOI 10.1016/j.celrep.2025.116909↗
- Paper SPP1 is required for maintaining mesenchymal cell fate in pancreatic cancer. DOI 10.1038/s41586-025-09574-y↗
- Huafu Li · 3 shared papers, 2022–2026 · strength 0.59
- Paper A Jagged1-regulated hybrid-EMT state identifies pancreatic cancer stem cells. DOI 10.1016/j.celrep.2025.116909↗
- Paper SPP1 is required for maintaining mesenchymal cell fate in pancreatic cancer. DOI 10.1038/s41586-025-09574-y↗
- Paper GREM1 is required to maintain cellular heterogeneity in pancreatic cancer. DOI 10.1038/s41586-022-04888-7↗
- Theodore Evan · 4 shared papers, 2019–2022 · strength 0.58
- Paper The roles of intratumour heterogeneity in the biology and treatment of pancreatic ductal adenocarcinoma. DOI 10.1038/s41388-022-02448-x↗
- Paper USP25 promotes pathological HIF-1-driven metabolic reprogramming and is a potential therapeutic target in pancreatic ca… DOI 10.1038/s41467-022-29684-9↗
- Paper GREM1 is required to maintain cellular heterogeneity in pancreatic cancer. DOI 10.1038/s41586-022-04888-7↗
- Jessica Kristine Nelson · 3 shared papers, 2022–2025 · strength 0.43
- Paper SPP1 is required for maintaining mesenchymal cell fate in pancreatic cancer. DOI 10.1038/s41586-025-09574-y↗
- Paper USP25 promotes pathological HIF-1-driven metabolic reprogramming and is a potential therapeutic target in pancreatic ca… DOI 10.1038/s41467-022-29684-9↗
- Paper GREM1 is required to maintain cellular heterogeneity in pancreatic cancer. DOI 10.1038/s41586-022-04888-7↗
- Victoria M.-Y. Wang · 3 shared papers, 2019–2022 · strength 0.42
- Paper The roles of intratumour heterogeneity in the biology and treatment of pancreatic ductal adenocarcinoma. DOI 10.1038/s41388-022-02448-x↗
- Paper CD9 identifies pancreatic cancer stem cells and modulates glutamine metabolism to fuel tumour growth. DOI 10.1038/s41556-019-0407-1↗
- Paper MDH1 and MPP7 Regulate Autophagy in Pancreatic Ductal Adenocarcinoma. DOI 10.1158/0008-5472.can-18-2553↗
- Xintong Zhang · 1 shared paper, 2025 · strength 0.37
- Anguraj Sadanandam · 2 shared papers, 2022–2025 · strength 0.31
- Omar M. Khan · 1 shared paper, 2023 · strength 0.26
- Amira Kohil · 1 shared paper, 2023 · strength 0.26
- Yoh Zen · 2 shared papers, 2022 · strength 0.24
- Tingzhuang Yi · 1 shared paper, 2025 · strength 0.19
- Andreas A. Prachalias · 1 shared paper, 2022 · strength 0.12
- Debashis Sarker · 1 shared paper, 2022 · strength 0.12
- Maria I. New · 1 shared paper, 2019 · strength 0.08
- Sharon A. Tooze · 1 shared paper, 2019 · strength 0.08
- Kevin M. Ryan · 1 shared paper, 2019 · strength 0.08
- Ralph Gruber · 1 shared paper, 2016 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.